Biopharmaceutical company formed from Sosei Group and Heptares Therapeutics, specialising in structure-based drug discovery targeting GPCRs.
Former members 1
Related organizations
Based on public sources. If accuracy is important, verify details using the links or references.
For corrections, updates, or requests to remove information, contact us.